birth control pills Tagged Articles

Watchdog group pushes FDA panel to revote on Yaz safety

Posted: January 26, 2012 Pharmaceutical

A consumer watchdog group is calling for a revote by a Food and Drug Administration (FDA) advisory panel, after discovering that some members of the panel had ties to drug companies that made the pills under review.

First Yaz trial will be April 30 if mediation fails

Posted: January 20, 2012 Pharmaceutical

If mediation fails between Bayer and lawyers for the defendant, the first Yaz/Yasmin trial against the drug company will start on April 30. U.S. District Judge David Herndon ordered the mediation earlier this month in an attempt to settle the

FDA panel members had ties to Yaz maker

Posted: January 19, 2012 Pharmaceutical

Last month, an advisory panel for the Food and Drug Administration (FDA) pored over data that showed women who took birth control pills containing the hormone drospirenone were at greater risk of developing blood clots than women on older generation

First Yaz lawsuit ordered to mediation for potential settlement

Posted: January 9, 2012 Pharmaceutical

The first of more than 10,000 lawsuits against Bayer over its birth control pills Yaz and Yasmin won’t go to trial this week as planned because a judge appointed a mediator in hopes of settling the case. The lawsuit accused

No breastfeeding plus birth control pills may increase risk of breast cancer

Posted: January 6, 2012 Pharmaceutical

Women who use birth control pills and have never breastfed are at as great of a risk of developing breast cancer as women with a family history, according to a new study published in the Indian Journal of Cancer.

Drug companies may delay, withhold trial data from medical journals

Posted: January 5, 2012 Pharmaceutical

Missing data from clinical trials that test the safety and efficacy of pharmaceutical drugs “distorts scientific record” and puts patients lives in danger, the British Medical Journal warns. The medical publication, which serves as a resource for policy makers and

Pros and cons of birth control pills for nuns

Posted: January 4, 2012 Pharmaceutical

For centuries, nuns have been at greater risk for developing breast, ovarian and uterine cancers – diseases that are more common in women who do not have children. But a new study published in The Lancet suggests nuns could greatly

Women should be aware of blood clot risk with birth control pills, patches

Posted: January 3, 2012 Pharmaceutical

The recent recommendations from a Food and Drug Administration (FDA) advisory committee about safety concerns with contraceptives may make women more leery when deciding which birth control is best for them. But even for women who are currently on birth

FDA panel warns of elevated blood clot risk with patch, Yaz

Posted: December 28, 2011 Pharmaceutical

A Food and Drug Administration (FDA) advisory panel said Friday that the Ortho Evra birth control patch, made by Johnson & Johnson, should remain on the market despite an elevated risk for blood clots. The panel voted 19-5 in favor

Blood clot warnings on birth control pills could impact user rates

Posted: December 27, 2011 Pharmaceutical

Stronger warnings on packages of a newer class of birth control pills and government ruling to restrict the availability of the morning-after pill may make women leery of birth control in general, which could increase the rate of unwanted pregnancies